New York State Common Retirement Fund
VOR icon

New York State Common Retirement Fund’s Vor Biopharma VOR Stock Holding History

New York State Common Retirement Fund’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-16
Closed -$322 – 3347
2024
Q2 		$322 Sell
16
-1,077
-99% -$34.8K ﹤0.01% 3363
2024
Q1 		$51.8K Buy
1,093
+18
+2% +$790 ﹤0.01% 2972
2023
Q4 		$48.4K Sell
1,075
-6
-0.6% -$248 ﹤0.01% 3007
2023
Q3 		$45.8K Buy
1,081
+21
+2% +$1.14K ﹤0.01% 3046
2023
Q2 		$65.5K Buy
+1,060
New +$96.8K ﹤0.01% 3075
2022
Q3 		– Sell
-10
Closed -$1K – 3458
2022
Q2 		$1K Sell
10
-525
-98% -$53.7K ﹤0.01% 3419
2022
Q1 		$65K Buy
535
+3
+0.6% +$511 ﹤0.01% 3115
2021
Q4 		$124K Buy
532
+142
+36% +$40.9K ﹤0.01% 3021
2021
Q3 		$122K Sell
390
-175
-31% -$52K ﹤0.01% 3079
2021
Q2 		$211K Buy
565
+135
+31% +$66.6K ﹤0.01% 3024
2021
Q1 		$371K Buy
+430
New +$364K ﹤0.01% 2584

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

New York State Common Retirement Fund's VOR Position: Q3 2024 in Review

New York State Common Retirement Fund sold out of Vor Biopharma (VOR) in Q3 2024, closing a stake of 16 shares — an estimated $322 sold.

New York State Common Retirement Fund first reported a position in VOR in Q1 2021 and held it in 11 quarters. The position peaked at $371K in Q1 2021. 54 funds tracked by Wall St. Rank hold VOR as of Q3 2024.

  • New York State Common Retirement Fund reported no remaining Vor Biopharma position as of Q3 2024 after selling out during the quarter.
  • New York State Common Retirement Fund sold 16 Vor Biopharma shares in Q3 2024, an estimated $322.
  • New York State Common Retirement Fund first reported a position in Vor Biopharma in Q1 2021 and held it in 11 quarters.
  • New York State Common Retirement Fund's Vor Biopharma position peaked at $371K in Q1 2021.
  • 54 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2024.

Based on New York State Common Retirement Fund's 13F filing for Q3 2024, filed 28 Oct 2024.